Average Co-Inventor Count = 5.04
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Salix Pharmaceuticals, Inc. (9 from 63 patents)
2. Warner-Lambert Company (2 from 2,538 patents)
3. Other (1 from 832,880 patents)
4. Bayer Intellectual Property Gmbh (1 from 721 patents)
5. Alfa Wassermann, Inc. (1 from 88 patents)
6. Noramco Gmbh (1 from 25 patents)
14 patents:
1. 9700545 - Forms of rifaximin and uses thereof
2. 9546183 - Forms of rifaximin and uses thereof
3. 9359357 - Forms of rifaximin and uses thereof
4. 9273066 - Forms of rifaximin and uses thereof
5. 9181274 - Forms of rifaximin and uses thereof
6. 9034892 - Forms of rifaximin and uses thereof
7. 8754098 - Forms of rifaximin and uses thereof
8. 8569326 - Forms of rifaximin and uses thereof
9. 8563571 - Crystalline forms of oxymorphone hydrochloride
10. 8486956 - Forms of rifaximin and uses thereof
11. 8466280 - Co-crystal compound of rivaroxaban and malonic acid
12. 8067429 - Forms of rifaximin and uses thereof
13. 7144915 - Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
14. 6605729 - Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)